The Impact of Incarceration Upon Adherence to HIV Treatment Among HIV-Positive Injection Drug Users: A Qualitative Study
July 7, 2009
"HIV-positive injection drug users (IDU) often do not derive the full benefits of highly active antiretroviral therapy (HAART). Among IDU, recent incarceration has been associated with discontinuation of HAART for non-clinical reasons," explained the study authors. In order to identify factors influencing treatment adherence, they sought to qualitatively evaluate experiences with HAART among recently incarcerated HIV-positive IDU in British Columbia.
"The current study identified contextual factors within correctional environments that hinder individuals' ability to adhere to HAART," the researchers concluded. "These findings also indicated that improved health services and coordination with community care providers are needed to enhance the quality of HIV treatment within correctional environments."
Improved Drug Treatment Services Needed in Prisons to Address HIV/AIDS, Other Diseases, Editorial Says
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.